New Actuary CPD Tracker · all of your CPD in one app actuarycpd.com →
Tag

Pharmacy Cost Trends

Prescription drug spending trends, specialty pharmacy costs, and their impact on health insurance pricing.

Recent News

Opioid prescriptions plunge, but questions remain over alternative pain treatments

Business Insurance

Few Americans say CDC, FDA are doing a good job: survey

Fierce Healthcare

Health Community: Rebalancing Risk in Gene Therapy & High-Cost Pharmaceuticals

SOA Podcasts

2026 Employer Health Benefits Survey

KFF

Cencora to acquire majority stake in $2.4B American Oncology Network

Fierce Healthcare

As Politicians Argue About China, US Patients Find Cutting-Edge Treatment There

KFF Health News

More Medications, More Risks. If You’re Worried, Start a Deprescribing Discussion.

KFF Health News

A Better Way to Manage Workers’ Comp Claim Decisions: 6 Steps to More Effective Pharmacy Workflows

Risk & Insurance

Drugmakers seek to intervene in lawsuit challenging 340B pilot

Healthcare Dive

GOP Focuses on Fraud, Seeking To Redirect Voters’ Ire Over Healthcare Costs

KFF Health News

Four Red Flags and One Truth Amid the Peptide Hype

KFF Health News

Epic teams up with Amazon Pharmacy, Eli Lilly and Mark Cuban to launch prescription drug pricing tool

Fierce Healthcare

FDA ‘reset’ continues with new plan for reviewing rare disease drugs

Healthcare Dive

Walmart to expand health benefits for employees, including $0 prescriptions, rare disease care

Fierce Healthcare

CVS to pay $315M to settle opioid prescribing allegations

Healthcare Dive

CVS, DOJ reach $315M settlement in opioid prescription case

Fierce Healthcare

People Say These Peptides Hurt Them. Their Stories Are Muffled in MAHA’s Push for Medical Freedom.

KFF Health News

Hospitals sue over revamped 340B rebate pilot

Healthcare Dive

Hospital industry sues to block HHS' 340B rebate pilot (again)

Fierce Healthcare

HHS: 340B 'expanded beyond its original intent,' incentivizes consolidation

Fierce Healthcare

PhRMA launches new legal challenge as CMS brings 'most favored nation' pricing to Medicare Part B

Fierce Healthcare

CD&R, McKesson acquiring infusion therapy provider Option Care Health for $5.8B

Fierce Healthcare

When rebates rise but pharmacy costs keep climbing

Insurance Business

Employers are getting hurt most by $12.7 billion specialty drug waste

Insurance Business

PBM disclosure rules still leave benefits brokers with unanswered questions

Insurance Business

Most postpartum GLP-1 starters had no qualifying diagnosis, US study finds

Insurance Business

Doctors Should Keep an Eye on Your Mix of Medication. If They Don’t, You Should.

KFF Health News

HRSA names 10 drugmakers for revised 340B rebate pilot ahead of 2027 launch

Fierce Healthcare

GLP-1 Drugs Force Insurers to Weigh Today’s Pharmacy Bill Against Tomorrow’s Health Savings

Risk & Insurance

Why Prime Therapeutics is betting on bridging the gaps between medical, pharmacy benefits

Fierce Healthcare
Featured Analysis

Healthcare Cost Trends 2026: What Actuaries Need to Know About the Forces Reshaping Medical Spending

Medical cost trends at 8.5–9.5%, GLP-1 drug costs reshaping pharmacy spend, behavioral health surges, oncology spending acceleration, and actuarial implications for pricing, reserving, and employer plan design.

Read article →
← Browse all Insights